Healthcare Magazine September 2015 | Page 85

LATIN AMERICA
1 . To consolidate acquisitions in the regional market .

Key People

2 . Increase regional market share .
3 . Improve operational efficiency to maximize profitability .
“ During 2016 , we will be consolidating all acquisitions , particularly , by improving our market share ,” added Sosa . In addition , they seek to strengthen their infant formula products and Aspen Pharma prescription drugs .
“ Our focus this year is in organic growth . We are participating more actively in medical conferences to maintain closeness with pediatricians and neonatologists , revealing our alternative formulas , which are the most similar to breast milk , “ emphasized Carlos Abelleyra , CEO of Aspen Labs in Latin America ( Spanish-speaking ) and entrepreneur with more than 30 years of experience in the pharmaceutical industry .
In the medium term , the company will continue to expand its portfolio by reaching new public and private markets , as in the case of its next export to Australia ; They also discussed future acquisitions both globally and in Latin America ( excluding Brazil ). “ At the moment we are in the financial analysis period of a next acquisition in Argentina ,” added Abelleyra .
Carlos Abelleyra CEO of Aspen Labs Latin America
Expresident of CANIFARMA and former CEO of Wyeth Mexico and Central America ( from March 2002 until August 2008 ). During his tenure , Wyeth was among the leading companies in biotech drugs , vaccines , women ’ s health and infant formulas ; Wyeth also gained recognition as a Socially Responsible Company , A Great Place to Work and was awarded in Ethics and Values . From March 2003 to February 2005 , he became president of LAWG , the group that integrates leading US pharmaceutical companies with operations in Mexico ( Abbott , Bristol-Myers Squibb , GSK , Eli Lilly , Janssen- Cilag , MSD , Pfizer , Schering Plough and Wyeth ). With more than 30 years of industry experience , Carlos Abelleyra has served as Commercial Vice President of Wyeth , Commercial Director of Aventis , Director of Sales and Market Development at Bristol Myers Squibb and responsible for sales and marketing of Johnson & Johnson Mexico .
www . aspenlabs . com . mx 85